NCOG-32. THE SAFETY AND EFFICACY OF DEXAMETHASONE IN THE MANAGEMENT OF GLIOMA PATIENTS

Dexamethasone is routinely administered to glioma patients for the management of cerebral edema. Dexamethasone is associated with significant side effects including hyperglycemia, increased risk of infection, and impaired anti-tumor immune response. Despite these risks, there are no standardized gui...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Medikonda, Ravi, Patel, Kisha, Saleh, Laura, Srivastava, Siddhartha, Jackson, Christina, Mohan, Aditya, Weingart, Jon, Bettegowda, Chetan, Gallia, Gary, Brem, Henry, Lim, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Outcome Measures and Neuro-Cognitive Outcomes
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651049/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.570
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak